Gilead Sciences: Dividends, Buybacks, and M&A?
November 03, 2016 at 09:57 AM EDT
Following Gilead Sciences' ( GILD ) third-quarter earning s, Maxim's Jason Kolbert and team wonder where the biotech giant goes from here:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.